Twelve out-patients with established angina pectoris who had previously participated in a double-blind trial of prenylamine lactate continued to record their daily anginal attack rate and glyceryl trinitrate consumption over the subsequent 18 months. The improvement noted while taking prenylamine during the trial was maintained and a further double-blind study confirmed that this was, in fact, due to the administration of the drug, which was again shown to be significantly more effective than identical placebo in the prophylaxis of angina pectoris.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.